France · Series A startup

Who invested in EVerZom

One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$12Mraised across 1 round since 2025, from 1 source

Latest round
Series A, $12MOct 2025
Investors
3
See who backed them

The rounds

  1. Oct 2025
    Series A$12M

    Source recorded

Founders and team

From EVerZom's own website: 2 founders, 5 on the team.

Jeanne VolatronCEO and Co founder
Nicolas RousseauCCO & Co founder
  • Julien BranchuHead of the R&D
  • Isaure RousR&D engineer
  • Maxence DucheminR&D engineer and project leader
  • Pauline TalbotR&D engineer
  • Shony LemieuxR&D and Production engineer assistant

Everyone who backed them

BpifranceGovernment1round
EIC AcceleratorGovernment1round
Capital CellVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about EVerZom

Who invested in EVerZom?

EVerZom's investors include Bpifrance, EIC Accelerator and Capital Cell.

How much has EVerZom raised?

EVerZom has raised $12M across 1 round since 2025.

When did EVerZom last raise?

EVerZom's most recent round was a Series A of $12M in Oct 2025.

What was EVerZom's biggest round?

Its most recent round, $12M in Oct 2025, is also its largest on record.

Who backed EVerZom first?

EVerZom's first round on record, in Oct 2025, was backed by Bpifrance, EIC Accelerator and Capital Cell.

What stage is EVerZom at?

EVerZom's latest named round is a Series A, in Oct 2025.

Where is EVerZom based?

EVerZom is based in France.

Companies like EVerZom

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.